GENERAL CATALOGUE
Trastuzumab envedotin
HY-172820 · 50 mg
MedChemExpress · Cat: HY-172820
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/trastuzumab-envedotin.htmlCatalog No: HY-172820
Category: Antibody-drug Conjugate ADC Related
Pack Size: 50 mg
Brand: MedChemExpress
Description
Trastuzumab envedotin DP303c is a anti-human epidermal growth factor receptor 2 HER2 antibody-drug conjugate ADC . Trastuzumab envedotin is composed of the tubulin polymerization inhibitor Monomethyl auristatin E MMAE HY-15162 to the anti-HER2 antibody DP001 via a cleavable linker. Trastuzumab envedotin can be used for the research of HER2-positive solid tumors, such as breast cancer, colorectal cancer, and gastric cancer.
More from MedChemExpress
Rha-PEG3-SMCC
HY-142740
Antibody-drug Conjugate ADC Related
PPC-NB
HY-126530
Antibody-drug Conjugate ADC Related
Taltobulin intermediate-8
HY-41070
Antibody-drug Conjugate ADC Related
m-PEG8-NHS ester
HY-W019793
Antibody-drug Conjugate ADC Related
Mal-amido-PEG5-C2-NHS ester
HY-126508
Antibody-drug Conjugate ADC Related
Tisotumab vedotin
HY-152963
Antibody-drug Conjugate ADC Related
Muscotoxin A
HY-131058
Antibody-drug Conjugate ADC Related
Methylcyclopropene-PEG4-NHS
HY-136048
Antibody-drug Conjugate ADC Related